|
|
|
|
|
|
|
|
NIOSH Publication No. 2005-109:Histoplasmosis — Protecting Workers at Risk |
December 2004 |
|
||
References
1. Heymann DL, ed. [2004]. Control of communicable diseases manual. 18th ed. Washington, DC: American Public Health Association, pp. 273–275.
2. Walsh TJ, Larone DH, Schell WA, Mitchell TG [2003]. Chapter 118: Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. In: Murray PR, editor-in-chief. Manual of clinical microbiology. 8th ed. Washington, DC: American Society for Microbiology Press, pp. 1781–1797.
3. Deepe GS Jr. [2000]. Chapter 254: Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, pp. 2718–2733s.
4. Cano MVC, Hajjeh RA [2001]. The epidemiology of histoplasmosis: a review. Semin. Respir. Infect. 16(2):109–118.
5. Wheat LJ [2000]. Chapter 3: Histoplasmosis. In: Sarosi GA, Davies SF, eds. Fungal Diseases of the Lung. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, pp. 31–46.
6. Johnson PC, Sarosi GA [1987]. Histoplasmosis. Semin. Respir. Med. 9(2):145–151.
7. Larsh HW [1983]. Histoplasmosis. In: DiSalvo AF, ed. Occupational mycoses. Philadelphia, PA: Lea and Febiger, pp. 29–41.
8. Mitchell TG [1992]. Systemic mycoses. In: Joklik WK, Willett HP, Amos DB, Wifert CM, eds. Zinsser microbiology. 20th ed. Norwalk, CT: Appleton and Lange, pp. 1091–1112.
9. Furcolow ML, Schubert J, Tosh FE, Doto IL, Lynch HJ Jr. [1962]. Serologic evidence of histoplasmosis in sanatoriums in the US. JAMA 180:109–114.
10. Wheat LJ, Kauffman CA [2003]. Histoplasmosis. Fungal infections, part II: recent advances in diagnosis, treatment, and prevention of endemic and cutaneous mycoses. Infect. Dis. Clin. N. Am. 17:1–19.
11. Wheat J, Sarosi G, McKinsey D, Hamill R, Bradsher R, Johnson P, Loyd J, Kauffman C [2000]. Practice guidelines for the management of patients with histoplasmosis. Clin. Infect. Dis. 30:688–695.
12. Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML [1990]. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Med. 69(6):361–374.
13. Deepe GS [1994]. The immune response to Histoplasma capsulatum: unearthing its secrets. J. Lab. Clin. Med. 123:201–205.
14. Davies SF [1990]. Histoplasmosis: update 1989. Semin. Respir. Infections 5 (2):93–104.
15. Hajjeh RA [1995]. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin. Infectious Dis. 21 (Suppl 1):S108–S110.
16. Wheat LJ, Slama TG, Zeckel ML [1985]. Histoplasmosis in the acquired immune deficiency syndrome. Am. J. Med. 78:203–210.
17. Greenfield RA [1989]. Pulmonary infections due to higher bacteria and fungi in the immuno compromised host. Semin. Respir. Med. 10:68–77.
18. Selik RM, Karon JM, Ward JW [1997]. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J. Infect. Dis. 176:632–636.
19. Deepe GS Jr. [1997]. Histoplasma capsulatum: Darling of the river valleys. ASM News 63:599–604.
20. Ciulla TA [undated]. Presumed ocular histoplasmosis syndrome. Available from the Web site of MiraVisa Diagnostics. [http://www.miravistalabs.com/refLibrary_reviews_page.php?id=40]. Date accessed: September 2004.
21. National Eye Institute [2004]. Histoplasmosis. [http://www.nei.nih.gov/health/histoplasmosis/index.asp]. Date accessed: September 2004.
22. Schwarz J [1981]. Histoplasmosis of the eye. In: Histoplasmosis. New York, NY: Praeger Publishers, pp. 317–350.
23. Newell FW [1992]. Ophthalmology principles and concepts. 7th ed. St. Louis, MO: Mosby Year Book, p. 439.
24. Daniel TM, Baum GL [2002]. Drama and discovery, the story of histoplasmosis. Westport, CN: Greenwood Press, p. 109.
25. Wheat LJ [1992]. Histoplasmosis in Indianapolis. Clin. Infectious Dis. 14 (Suppl 1):S91–S99.
26. Wheat J, French MLV, Kohler RB, Zimmerman SE, Smith CD, Slama TG [1982]. The diagnostic laboratory tests for histoplasmosis. Ann. Int. Med. 97(5):680–685.
27. George RB, Penn RL [1986]. Histoplasmosis. In: Sarosi GA, Davies SF, eds. Fungal diseases of the lung. Orlando, FL: Harcourt Brace Jovanovich, pp. 69–85.
28. Bracca A, Tosello ME, Girardini JE, Amigot SL, Gomez C, Serra E [2003]. Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J. Clin. Microbiol. 41:1753–1755.
29. Guedes HL, Guimarães AJ, Muniz M, Pizzini VC, Hamilton AJ, Peralta JM, Deepe GS Jr, Zancopé-Oliveira RM [2003]. PCR assay for identification of Histoplasma capsulatum based on the nucleotide sequence of the M antigen. J. Clin. Microbiol. 41:535–539.
30. Rickerts V, Bialek R, Tintelnot K, Jacobi V, Just-Nübling G [2002]. Rapid PCR-based diagnosis of disseminated histoplasmosis in an AIDS patient. Eur. J. Clin. Infect. Dis. 21:821–823.
31. Reiss E, Kaufman L, Kovacs JA, Lindsley MD [2002]. Chapter 61: Clinical immunomycology. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of clinical laboratory immunology. 6th ed. Washington, DC: American Society for Microbiology Press, pp. 559–583.
32. Sutton DA [2003]. Chapter 111: Specimen collection, transport, and processing: mycology. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th ed. Washington, DC: American Society for Microbiology Press, pp. 1659–1667.
33. Richmond RY, McKinney RW, eds. [1999]. Biosafety in microbiological and biomedical laboratories. 4th ed. [http://www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4toc.htm]. Date accessed: September 2004.
34. Rippon JW [1988]. Chapter 15: Histoplasmosis (histoplasmosis capsulati and histoplasmosis farciminosum).In: Medical mycology: the pathogenic fungi and the pathogenic actinomycetes.3rd ed. Philadelphia, PA: W.B. Saunders Company, pp. 381–423.
35. Wheat LJ, Kohler RB, Tewari RP:[1986]. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 314:83–88.
36. Wheat LJ, Connolly-Stringfield P, Kohler RB, Frame PT, Gupta MR [1989]. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 87:396–400.
37. Edwards LB, Acquaviva FA, Livesay VT [1973]. Further observations on histoplasmin sensitivity in the United States. Am. J. Epidemiol. 98(5):315–325.
38. Ajello L, Weeks RJ [1983]. Soil decontamination and other control measures. In: DiSalvo AF, ed. Occupational mycoses. Philadelphia, PA: Lea and Febiger, pp. 229–238.
39. Stobierski MG, Hospedales CJ, Hall WN, Robinson-Dunn B, Hoch D, Sheill DA [1996]. Outbreak of histoplasmosis among employees in a paper factory— Michigan, 1993. J. Clin. Microbiol. 34(5):1220–1223.
40. Morse DL, Gordon MA, Matte T, Eadie G [1985]. An outbreak of histoplasmosis in a prison. Am. J. Epidemiol. 122(2):253–261.
41. Bartlett PC, Weeks RJ, Ajello L [1982]. Decontamination of Histoplasma capsulatum-infested bird roost in Illinois. Arch. Environ. Health 37:221–223.
42. Gustafson TL, Kaufman L, Weeks R, Ajello L, Hutcheson RH, Wiener SL, et al. [1981]. Outbreak of acute pulmonary histoplasmosis in members of a wagon train. Am. J. Med. 71:759–765.
43. Chick EW, Compton SB, Pass III T, Mackey B, Hernandez C, Austin Jr E, et al. [1981]. Hitchcock’s birds, or the increased rate of exposure to Histoplasma from blackbird roost sites. Chest 80(4):434–438.
44. Storch G, Burford JG, George RB, Kaufman L, Ajello L [1980]. Acute histoplasmosis. Description of an outbreak in northern Louisiana. Chest 77:38–42.
45. DiSalvo AF, Johnson WM [1979]. Histoplasmosis in South Carolina: support for the microfocus concept. Am. J. Epidemiol. 109(4):480–492.
46. Latham RH, Kaiser AB, Dupont WD, Dan BB [1980]. Chronic pulmonary histoplasmosis following the excavation of a bird roost. Am. J. Med. 68:504–508.
47. Sarosi GA, Parker JD, Tosh FE [1971]. Histoplasmosis outbreaks: their patterns. In: Ajello L, Chick EW, Furcolow ML, eds. Histoplasmosis: proceedings of the second national conference. Springfield, IL: Charles C. Thomas, pp. 123–128.
48. Tosh FE, Weeks RJ, Pfeiffer FR, Hendricks SL, Greer DL, Chin TDY [1967]. The use of formalin to kill Histoplasma capsulatum at an epidemic site. Am. J. Epidemiol. 85:259–265.
49. Tosh FE, Weeks RJ, Pfeiffer FR, Hendricks SL, Chin TDY [1966]. Chemical decontamination of soil containing Histoplasma capsulatum. Am. J. Epidemiol. 83:262–270.
50. Tosh FE, Doto IL, D'Alessio DJ, Medeiros AA, Hendricks SL, Chin TDY [1966]. The second of two epidemics of histoplasmosis resulting from work on the same starling roost. Am. Rev. Respir. Dis. 94:406–413.
51. Weeks RJ [1984]. Histoplasmosis sources of infection and methods of control. Atlanta, GA: Centers for Disease Control and Prevention.
52. Dean AG, Bates JH, Sorrels C, Sorrels T, Germany W, Ajello L, Kaufman L, McGrew C, Fitts A [1978]. An outbreak of histoplasmosis at an Arkansas courthouse, with five cases of probable reinfection. Am. J. Epidemiol. 108:36–46.
53. Raphael SS, Schwarz J [1953]. Occupational hazards from fungi causing deep mycoses. Arch. Ind. Hyg. Occup. Med. 8:154–165.
54. Felson B, Jones GF, Ulrich RP [1950]. Roentgenologic aspects of diffuse miliary granulomatous pneumonitis of unknown etiology: report of twelve cases with eighteen months’ follow-up. Am. J. Roentgenol. Radium Ther. 64(5):740–746.
55. Jones TF, Swinger GL, Craig AS, McNeil MM, Kaufman L, Schaffner W [1999]. Acute pulmonary histoplasmosis in bridge workers: a persistent problem. Am. J. Med. 106:480–482.
56. Valdez H, Salata RA [1999]. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J. Travel Med. 6:258–260.
57. Leslie L, Arnette C, Sikder A, Adams J, Holbrook C, Bond J, King B, Roberts K, Patrick MS, Palmer C, Finger R, Tomford JW, Rushton T [1995]. Histoplasmosis— Kentucky, 1995. MMWR 44(38):701–703.
58. Lenhart SW [1994]. Recommendations for protecting workers from Histoplasma capsulatum exposure during bat guano removal from a church's attic. Appl. Occup. Environ. Hyg. 9:230–236.
59. Gordon SM, Reines SS, Alvarado CS, Nolte F, Keyserling HL, Bryan J [1993]. Disseminated histoplasmosis caused by Histoplasma capsulatum in an immuno compromised adolescent after exploration of a bat cave. Pediatric Infect. Dis. J. 12(1):102–104.
60. Sacks JJ, Ajello L, Crockett LK [1986]. An outbreak and review of cave-associated histoplasmosis capsulati. J. Med. Vet. Mycol. 24:313–325.
61. Bartlett PC, Vonbehren LA, Tewari RP, Martin RJ, Eagleton L, Isaac MJ, Kulkarni PS [1982]. Bats in the belfry: an outbreak of histoplasmosis. Am. J. Public Health 72:1369–1372.
62. Schwarz J [1981]. Bats and soil. In: Histoplasmosis. New York, NY: Praeger Publishers, pp. 179–186.
63. Sorley DL, Levin ML, Warren JW, Flynn JPG, Gerstenblith J [1979]. Bat-associated histoplasmosis in Maryland bridge workers. Am. J. Med. 67:623–626.
64. Chick EW, Bauman DS, Lapp NL, Morgan WKC [1972]. A combined field and laboratory epidemic of histoplasmosis. Am. Rev. Respir. Dis. 105:968–971.
65. DiSalvo AF [1971]. The role of bats in the ecology of Histoplasma capsulatum. In: Ajello L, Chick EW, Furcolow ML, eds. Histoplasmosis: proceedings of the second national conference. Springfield, IL: Charles C. Thomas, pp. 149–161.
66. Gordon MA, Ziment I [1967]. Epidemic of acute histoplasmosis in western New York State. N.Y. State J. Med. 67:235–243.
67. Ajello L, Hosty TS, Palmer J [1967]. Bat histoplasmosis in Alabama. Am. J. Trop. Med. Hyg. 16:329–331.
68. Hasenclever HF, Shacklette MH, Young RV, Gelderman GA [1967]. The natural occurrence of Histoplasma capsulatum in a cave—1. Epidemiologic aspects. Am. J. Epidemiol. 86(1):238–245.
69. Shacklette MH, Hasenclever HF, Miranda EA [1967]. The natural occurrence of Histoplasma capsulatum in a cave—2. Ecologic aspects. Am. J. Epidemiol. 86(1):246–252.
70. Shacklette MH, Hasenclever HF [1967]. The natural occurrence of Histoplasma capsulatum in a cave—
3. Effect of flooding. Am. J. Epidemiol. 88(2):210–252.71. Campins H, Zubillaga C, Lopez LG, Dorante M [1956]. An epidemic of histoplasmosis in Venezuela. Am. J. Trop. Med. 5:690–695.
72. Englert E, Phillips AW [1953]. Acute diffuse pulmonary granulomatosis in bridge workers. Am. J. Med. 15:733–740.
73. Scalia SP [1961]. An outbreak of histoplasmosis in Baltimore County. Maryland State Med. J. 10:614–619.
74. Lehan PH, Furcolow ML [1957]. Epidemic histoplasmosis. J. Chron. Dis. 5(4):489–503.
75. Furcolow ML, Menges RW, Larsh HW [1955]. An epidemic of histoplasmosis involving man and animals. Ann. Int. Med. 43:173–181.
76. Imbach MJ, Larsh HW, Furcolow ML [1954]. Epidemic histoplasmosis and airborne Histoplasma capsulatum. Proc. Soc. Exper. Biol. and Med. 85:72–74.
77. Zeidberg LD, Ajello L [1954]. Environmental factors influencing the occurrence of Histoplasma capsulatum and Microsporum gypseum in soil. J. Bacteriol. 68:156–159.
78. Kier JH, Campbell CC, Ajello L, Sutliff WD [1954]. Acute bronchopneumonic histoplasmosis following exposure to infected garden soil. J. Am. Med. Assoc. 155:1230–1232.
79. Schwarz J [1981]. Global epidemiology and distribution of histoplasmosis. In: Histoplasmosis. New York, NY: Praeger Publishers, p. 87.
80. Hasenclever HF [1979]. Impact of airborne pathogens in outdoor systems: histoplasmosis. In: Edmonds RL, ed. Aerobiology: the ecological systems approach. Stroudsburg, PA: Dowden, Hutchinson and Ross, Inc., pp. 199–208.
81. Kassa H, Harrington B, Bisesi MS [2001]. Risk of occupational exposure to Cryptosporidium, Giardia, and Campylobacter associated with the feces of giant Canada Geese. Appl. Occup. Environ. Hyg. 16:905–909.
82. Feare CJ, Sanders MF, Blasco R, Bishop JD [1999]. Canada goose (Branta canadensis) droppings as a potential source of pathogenic bacteria. J. Royal Soc. Promot. Health 119:146–155.
83. Converse K, Wolcott M, Docherty D, Cole R, [1999]. Screening for potential human pathogens in fecal material deposited by resident Canada geese on areas of public utility. Available from the Web site of the National Wildlife Health Center. [http://www.nwhc.usgs.gov/pub_metadata/canada_geese.html]. Date accessed: September 2004.
84. Ward JI, Weeks M, Allen M, Hutcheson RH Jr., Anderson R, Fraser DW et al. [1979]. Acute histoplasmosis: clinical, epidemiologic and serologic findings of an outbreak associated with exposure to a fallen tree. Am. J. Med. 66:587–595.
85. Schlech WF, Wheat LJ, Ho JL, French MLV, Weeks RJ, Kohler RB, Deane CE, Eitzen HE, Band JD [1983]. Recurrent urban histoplasmosis, Indianapolis, Indiana, 1980–1981. Am. J. Epidemiol. 118:301–312.
86. Schwarz J, Kauffman CA [1977]. Occupational hazards from deep mycoses. Arch. Dermatol. 113:1270–1275.
87. Reid TM, Schafer MP [1999]. Direct detection of Histoplasma capsulatum in soil suspensions by two-stage PCR. Mol. Cell. Probes 13:269–273.
88. Wheat LJ, Slama TG, Norton JA, Kohler RB, Eitzen HE, French MLV, Sathapatayavongs B [1982]. Risk factors for disseminated or fatal histoplasmosis, analysis of a large urban outbreak. Ann. Intern. Med. 96:159–163.
89. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA) [2001]. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. [http://www.aidsinfo.nih.gov/guidelines/op_infections /O-I_112801.pdf]. Date accessed: September 2004.
90. Wilcox KR Jr., Waisbren BA, Martin J [1958]. The Walworth, Wisconsin, epidemic of histoplasmosis. Ann. Intern. Med. 49:388–418.
91. Byrd RB, Leavey R, Trunk G [1975]. The Chanute histoplasmosis epidemic. Chest 68(6):791–795.
92. Brodsky AL, Gregg MB, Loewenstein MS, Kaufman L, Mallison GF [1973]. Outbreak of histoplasmosis associated with the 1970 earth day activities. Am. J. Med. 54:333–342.
93. Chamany S, Mirza S, Fleming J, Howell, Lenhart SW, Mortimer VD, et al. [2004]. A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr. Infect. Dis. J. (Vol. 23, No. 10).
94. G reenhall AM, Frantz SC [1994]. Bats In: Prevention and control of wildlife damage. [http://www.ces.ncsu.edu/nreos/wild/wildlife/wdc/]. Date accessed: September 2004.
95. Tuttle MD [1988]. America’s neighborhood bats. Austin, TX: University of Texas Press.
96. Bat Conservation International, Inc. [1996]. Exclusion experts promote pest control industry changes. Bats
14(2):10–11.97. Williams DE, Corrigan RM [1994]. Pigeons (rock doves). In: Prevention and control of wildlife damage. [http://www.ces.ncsu.edu/nreos/wild/wildlife/wdc/]. Date accessed: September 2004.
98. Agency for Toxic Substances and Disease Registry [1999]. Toxicological profile for formaldehyde. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service. [http://www.atsdr.cdc.gov/toxprofiles/tp111.pdf]. Date accessed: September 2004.
99. Smith CD, Furcolow ML, Tosh FE [1964]. Attempts to eliminate Histoplasma capsulatum from soil. Am. J. Hyg. 79(2):170–180.
100. CDC [1977]. Histoplasmosis control: decontamination of bird roosts, chicken houses and other point sources. Atlanta, GA: Centers for Disease Control and Prevention.
101. Wheat J [1997]. Histoplasmosis: experience during outbreaks in Indianapolis and review of the literature. Med. 76:339–354.
102. USDA, National Agricultural Statistics Service [2004]. Table 27. Poultry—inventory and number sold: 2002 and 1997. In: 2002 Census of Agriculture, Chapter 1. United States data.
103. Lenhart SW, Morris PD, Akin RE, Olenchock SA, Service WS, Boone WP [1990]. Organic dust, endotoxin, and ammonia exposures in the North Carolina poultry processing industry. Appl. Occup. Environ. Hyg. 5(9):611–618.
104. Furcolow ML [1965]. Environmental aspects of histoplasmosis. Arch. Environ. Health 10:4–10.
105. Myers WR, Lenhart SW, Campbell D, Provost G [1983]. Letter to the editor; topic: respirator performance terminology. Am. Ind. Hyg. Assoc. J. 44(3):B25–B26.
106. NIOSH [2004]. NIOSH respirator selection logic. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Pub. No. 2005–100.
107. Occupational Safety and Health Administration. [2003]. Assigned protection factors; proposed rule. Federal Register 68(109):34114.
108. American National Standards Institute. [1992]. American national standard for respiratory protection (ANSI Z88.2-1992). New York, NY: American National Standards Institute.
109. Lenhart SW, Seitz T, Trout D, Bollinger N [2004]. Issues affecting respirator selection for workers exposed to infectious aerosols: emphasis on healthcare settings. Applied Biosafety 9:20–36.
110. Furcolow ML [1961]. Airborne histoplasmosis. Bacteriological Rev. 25:301–309.
111. Imbach MJ, Larsh HW, Furcolow ML [1954]. Isolation of Histoplasma capsulatum from the air. Science 119:71.
112. NIOSH [1987]. NIOSH guide to industrial respiratory protection. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 87-116.
113. 63 Fed. Reg. 1152–1300 1998]. Occupational Safety and Health Administration: Respiratory protection; final rule. (Codified at 29 CFR Part 1910.134).
114. Oestenstad RK, Dillion HK, Perkins LL [1990]. Distribution of faceseal leak sites on a half-mask respirator and their association with facial dimensions. Am. Ind. Hyg. Assoc. J. 51:285–290.
115. 60 Fed. Reg. 30336 [1995]. National Institute for Occupational Safety and Health: Respiratory protective devices; final rule. (Codified at 42 CFR Part 84).
116. Campbell DL, Coffey CC, Lenhart SW [2001]. Respiratory protection as a function of respirator fitting characteristics and fit-test accuracy. Am. Ind. Hyg. Assoc. J. 62:36–44.
117. Coffey CC, Lawrence RB, Campbell DL, Zhuang Z, Calvert CA, Jensen PA [2004]. Fitting characteristics of eighteen N95 filtering-facepiece respirators. J. Occup. Environ. Hyg. 1:262–271.
118. Rey P, Meyer J-J [1998]. Vision and work. In: Stellman JM, ed. Encyclopaedia of Occupational Health and Safety. 4th ed. Geneva, Switzerland: International Labour Office, pp. 11.10–11.22.
119. Popendorf W, Merchant JA, Leonard S, Burmeister LF, Olenchock SA [1995]. Respirator protection and acceptability among agricultural workers. Appl. Occup. Environ. Hyg. 10(7):595–605.
120. USAEHA [1992]. Managing health hazards associated with bird and bat excrement. Aberdeen Proving Ground, MD: U. S. Army Environmental Hygiene Agency, U. S. Army Environmental Hygiene Agency Technical
Guide 142.121. Wigger-Alberti W, Elsner P [1998]. Do barrier creams and gloves prevent or provoke contact dermatitis? Am. J. Contact Dermatitis 9(2):100–106.
122. Mathias CGT [1990]. Prevention of occupational contact dermatitis. J. Am. Acad. Dermatol. 23:742–748.
123. Hajjeh RA, Brandt ME, Pinner RW [1995]. Emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery. Epidemiol. Rev. 17(2):303–320.
124. Levitz SM [1991]. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163–1169.
125. Pinner RW, Hajjeh RA, Powderly WG [1995]. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21 (Suppl 1):S103– S107.
126. Mitchell TJ, Perfect JR [1995]. Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515–548.
127. Kaplan JE, Masur H, Holmes KK, McNeil MM, Schonberger LB, Navin TR, et al. [1995]. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. Clin. Infect. Dis. 21 (suppl 1):S1–S11.
128. Centers for Disease Control and Prevention (CDC) [1997]. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 46 (No. RR-12):1–46.
129. Grose E, Marinkelle CJ, Striegel C [1968]. The use of tissue cultures in the identification of Cryptococcus neoformans isolated from Colombian bats. Sabouraudia 6:127–132.
130. Mitchell TG [1992]. Opportunistic mycoses. In: Joklik WK, Willett HP, Amos DB, Wifert CM, eds. Zinsser microbiology. 20th ed. Norwalk, CT: Appleton and Lange, pp. 1135–1157.
131. Ehrensing ER, Saag MS [2000]. Chapter 7: Cryptococcosis. In: Sarosi GA, Davies SF, eds. Fungal diseases of the lung. 3rd ed. Orlando, FL: Lippincott Williams and Wilkins, pp. 91–103.
132. Diamond RD [2000]. Chapter 253: Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, pp. 2707–2718.
133. Buchanan KL, Murphy JW [1998]. What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4:71–83.
134. Schlossberg D [2000]. Chapter 169: Chlamydia psittaci (Psittacosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, pp. 2004–2007.
135. Centers for Disease Control and Prevention (CDC) [2000]. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2000 and Compendium of animal rabies prevention and control, 2000: National Association of State Public Health Veterinarians, Inc. MMWR 49 (No. RR-8):1–17.
136. Heymann DL, ed. [2004]. Control of communicable diseases manual. 18th ed. Washington, DC: American Public Health Association, pp. 432–434.
137. Wyrick PB, Gutman LT, Hodinka RL [1992]. Chlamydiae. In: Joklik WK, Willett HP, Amos DB, Wifert CM, eds. Zinsser microbiology. 20th ed. Norwalk, CT: Appleton and Lange, pp. 719–729.
138. Centers for Disease Control and Prevention (CDC) [1990]. Psittaccosis at a turkey processing plant—North Carolina, 1989. MMWR 39(27):460–469.
139. Hooper DC [2002]. Rabies virus. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of clinical laboratory immunology. 6th ed. Washington, DC: American Society for Microbiology Press, pp. 742–748.
140. Bleck TP, Rupprecht CE [2000]. Chapter 151: Rabies virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, pp. 1811–1820.
141. Centers for Disease Control and Prevention (CDC) [2000]. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2000 and Compendium of animal rabies prevention and control, 2000: National Association of State Public Health Veterinarians, Inc. MMWR 49 (No. RR-8):19–30.
142. Centers for Disease Control and Prevention (CDC) [2004]. Compendium of animal rabies prevention and control, 2004: National Association of State Public Health Veterinarians, Inc. MMWR 53 (No. RR-9):1–6.
143. Rupprecht CE, Smith JS, Krebs J, Niezgoda M, Childs JE [1996]. Current issues in rabies prevention in the United States: health dilemmas, public coffers, private interests. Public Health Rep. 111:400–407.
144. Centers for Disease control and Prevention [1999]. Human rabies prevention – United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48 (No. RR-1):1–21.
1 45. Messenger SL, Smith JS, Rupprecht CE [2002]. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States . Clin. Infect. Dis. 35:738–747.
146. Centers for Disease Control and Prevention (CDC) [2004]. Human death associated with bat rabies—California, 2003. MMWR 53:33–35.
